National Acalabrutinib Observational Study
NCT05437250
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
350
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG:
Non interventional study
Sponsor
AstraZeneca